This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management of MS. The fourth edition has been extensively revised and features more than 50% new material.

An indispensable reference for researchers, research sponsors and neurologists interested in the rapidly developing field of multiple sclerosis therapeutics.